Health Check-up Market Size, Share & Trends Analysis Report By Type (General, Preventive, Specialized), By Test Type, By Application (Cardiovascular, Cancer), By Service Provider, By End-use, By Region, And Segment Forecasts, 2025 - 2030
Health Check-up Market Growth & Trends The global health check-up market size is expected to reach USD 79.18 billion by 2030, registering a CAGR of 6.8% from 2025 to 2030, according to a new rep... もっと見る
SummaryHealth Check-up Market Growth & TrendsThe global health check-up market size is expected to reach USD 79.18 billion by 2030, registering a CAGR of 6.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributable to the increasing awareness about general health among people, rising investments from government & non-government bodies, and the adoption of technologically advanced testing products across various healthcare platforms. For instance, in March 2021, F. Hoffmann-La Roche Ltd launched a connected blood glucose monitoring system under the Accu-Chek Instant System brand name. The connected system enables integrated and personalized diabetes management, to establish active care and communication between patient and healthcare provider. The increasing geriatric population across the economies is driving the demand for health check-ups, as elderly patients are more susceptible to chronic illnesses and require preventive healthcare. For instance, according to an article published by the WHO in October 2022, it is estimated that 1 in 6 people across the world will be aged above 60 by 2030. Hence, regulatory support to provide preventive care to the geriatric population will drive the health check-up industry. For example, the U.N. Decade of Healthy Ageing (2021-2030) aims to improve the elder population's lives by implementing four frameworks, such as delivering primary health services and dedicated care to the senior population. The growing deficiency of vitamins in the population drives the market for testing and monitoring. For instance, according to the National Institute of Health Database research published in October 2021, in the U.S., approximately 42% of the population is vitamin deficient. In addition, Frontiers Media S.A. published an article on February 2023, estimating that the global prevalence of vitamin deficiency from 2000 to 2022 was 15.7%, while the prevalence is anticipated to increase due to a sedentary lifestyle and low sunlight exposure. However, global medical device companies have continued to launch products to detect vitamin D levels at home and seek connected healthcare aid, driving the global health check-up industry. For instance, in April 2022, MediSure Labs launched the first Health Canada-approved Vitamin D home testing kit in the Canadian region. Moreover, key players operating in the global health check-up industry are focusing on strategic initiatives, such as product launches to increase their respective position in the marketplace. For instance, in January 2023, Burning Rock received breakthrough device designation from the U.S. FDA for its OverC Multi-Cancer detection blood test. The test helps in the early detection of esophageal, ovarian, pancreatic, liver, and lung cancer in adults aged 50-75 years. Furthermore, in February 2023, Dexcom, Inc. launched G7 continuous glucose monitoring system for beneficiaries with type 1 and type 2 diabetes, and the product will be covered by Medicare. Hence, the launch of next-generation testing products will allow the global health check-up industry to grow during the forecast period. Health Check-up Market Report Highlights • The general health check-up segment held the largest share of 36.58% in 2024. General health check-up provides a comprehensive overview of the individual’s health, helping to identify risk factors and manage the health condition at early stages. • The blood glucose tests held the largest market share of 21.86% in 2024, which can be attributed to the increasing cases of diabetes across the globe. Blood glucose tests, such as fasting blood sugar (FBS) and oral glucose tolerance tests (OGTT), are important in diagnosing and monitoring diabetes. • The cardiovascular diseases segment held the largest market share of 28.62% in 2024, attributed to increasing disease prevalence, high mortality rates, and advancement in testing products. • Hospital-based laboratories dominated the market with a share of 57.69% in 2024. Hospital-based laboratories are equipped with advanced medical equipment and infrastructure for conducting a wide range of diagnostic tests and screenings, thereby providing demand for the segment. • The individuals segment held the largest market share of 67.98% in 2024. It can be attributed to the increasing awareness of general & preventive health benefits amongst the general population. • North America health check-up market dominated with a share of 37.30% in 2024, it is due to the increasing healthcare coverage across the region. Table of ContentsTable of ContentsChapter 1 Methodology and Scope 1.1 Market Segmentation And Scope 1.1.1 Segment Definitions 1.1.1.1 Type Segment 1.1.1.2 Test Type Segment 1.1.1.3 Application Segment 1.1.1.4 Service Provider Segment 1.1.1.5 End Use Segment 1.2 Regional Scope 1.3 Estimates And Forecast Timeline 1.4 Objectives 1.4.1 Objective - 1 1.4.2 Objective - 2 1.4.3 Objective - 3 1.5 Research Methodology 1.6 Information Procurement 1.6.1 Purchased Database 1.6.2 Gvr’s Internal Database 1.6.3 Secondary Sources 1.6.4 Primary Research 1.7 Information Or Data Analysis 1.7.1 Data Analysis Models 1.8 Market Formulation & Validation 1.9 Model Details 1.9.1 Commodity Flow Analysis 1.10 List Of Secondary Sources 1.11 List Of Abbreviations Chapter 2 Executive Summary 2.1 Market Snapshot 2.2 Test And Test Type Segment Snapshot 2.3 Application And Service Provider Segment Snapshot 2.4 End Use Segment Snapshot 2.5 Competitive Landscape Snapshot Chapter 3 Global Health Check-up Market Variables, Trends, And Scope 3.1 Market Lineage Outlook 3.2 Market Dynamics 3.2.1 Market Driver Analysis 3.2.1.1 Increasing Prevalence Of Diseases 3.2.1.2 Growing Investments In Population Screening 3.2.1.3 Growing Geriatric Population 3.2.1.4 Adoption Of Digital Technology 3.2.2 Market Restraint Analysis 3.2.2.1 High Cost Associated With Screening 3.2.2.2 Psychological Factors And Knowledge, Attitudes, & Beliefs 3.2.3 Challenges 3.2.3.1 Lack Of Awareness 3.2.4 Opportunity 3.2.4.1 Rising Medical Tourism 3.3 Current & Future Market Opportunity Analysis 3.4 Business Environment Analysis Tools 3.4.1 Porter’s Five Forces Analysis 3.4.2 Pestle Analysis 3.5 Impact Of Covid-19: Qualitative Analysis Chapter 4 Global Health Check-up Market - Segment Analysis, By Type, 2018 - 2030 (USD Million) 4.1 Global Health Check-up Market: Type Movement Analysis 4.2 Global Health Check-up Market Estimates & Forecast, By Type (USD Million) 4.2.1 General Health Check-up 4.2.2 Preventive Health Check-up 4.2.3 Specialized Health Check-up 4.2.4 Routine & Wellness Check-up Chapter 5 Global Health Check-up Market - Segment Analysis, By Test Type, 2018 - 2030 (USD Million) 5.1 Global Health Check-up Market: Test Type Movement Analysis 5.2 Global Health Check-up Market Estimates & Forecast, By Test Type (USD Million) 5.2.1 Blood Glucose Tests 5.2.2 Kidney Function Tests 5.2.3 Bone Profile 5.2.4 Electrolytes 5.2.5 Liver Function Tests 5.2.6 Lipid Profile 5.2.7 Special Biochemistry 5.2.8 Cardiac Biomarkers 5.2.9 Hormones & Vitamins 5.2.10 Tumor Markers 5.2.11 Others Chapter 6 Global Health Check-up Market - Segment Analysis, By Application, 2018 - 2030 (USD Million) 6.1 Global Health Check-up Market: Application Movement Analysis 6.2 Global Health Check-up Market Estimates & Forecast, By Application (USD Million) 6.2.1 Cardiovascular Diseases 6.2.2 Metabolic Disorders 6.2.3 Cancer 6.2.4 Inflammatory Conditions 6.2.5 Musculoskeletal Disorders 6.2.6 Neurological Conditions 6.2.7 Others Chapter 7 Global Health Check-up Market - Segment Analysis, By Service Provider, 2018 - 2030 (USD Million) 7.1 Global Health Check-up Market: Service Provider Movement Analysis 7.2 Global Health Check-up Market Estimates & Forecast, By Service Provider (USD Million) 7.2.1 Hospital-based Laboratories 7.2.2 Central Laboratories 7.2.3 Standalone Laboratories Chapter 8 Global Health Check-up Market - Segment Analysis, By End Use, 2018 - 2030 (USD Million) 8.1 Global Health Check-up Market: End Use Movement Analysis 8.2 Global Health Check-up Market Estimates & Forecast, By End Use (USD Million) 8.2.1 Enterprise 8.2.2 Individuals Chapter 9 Global Health Check-up Market: Regional Estimates And Trend Analysis, By Type, Test Type, Service Provider, Application, & End Use 9.1 Global Health Check-up Market: Regional Outlook 9.2 North America 9.2.1 North America Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.2.2 U.S. 9.2.2.1 Key Country Dynamics 9.2.2.2 U.S. Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.2.2.3 Target Disease Prevalence 9.2.2.4 Competitive Scenario 9.2.2.5 Regulatory Framework 9.1.2.6 Reimbursement Scenario 9.2.3 Canada 9.2.3.1 Key Country Dynamics 9.2.3.2 Canada Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.2.3.3 Target Disease Prevalence 9.2.3.4 Competitive Scenario 9.2.3.5 Regulatory Framework 9.2.3.6 Reimbursement Scenario 9.2.3 Mexico 9.2.3.1 Key Country Dynamics 9.2.3.2 Mexico Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.2.3.3 Target Disease Prevalence 9.2.3.4 Competitive Scenario 9.2.3.5 Regulatory Framework 9.2.3.6 Reimbursement Scenario 9.3 Europe 9.3.1 North America Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.3.2 U.K. 9.3.2.1 Key Country Dynamics 9.3.2.2 U.K. Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.3.2.3 Target Disease Prevalence 9.3.2.4 Competitive Scenario 9.3.2.5 Regulatory Framework 9.3.2.6 Reimbursement Scenario 9.3.3 Germany 9.3.3.1 Key Country Dynamics 9.3.3.2 Germany Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.3.3.3 Target Disease Prevalence 9.3.3.4 Competitive Scenario 9.3.3.5 Regulatory Framework 9.3.3.6 Reimbursement Scenario 9.3.4 France 9.3.4.1 Key Country Dynamics 9.3.4.2 France Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.3.4.3 Target Disease Prevalence 9.3.4.4 Competitive Scenario 9.3.4.5 Regulatory Framework 9.3.4.6 Reimbursement Scenario 9.3.5 Spain 9.3.5.1 Key Country Dynamics 9.3.5.2 Spain Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.3.5.3 Target Disease Prevalence 9.3.5.4 Competitive Scenario 9.3.5.5 Regulatory Framework 9.3.5.6 Reimbursement Scenario 9.3.6 Italy 9.3.6.1 Key Country Dynamics 9.3.6.2 Italy Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.3.6.3 Target Disease Prevalence 9.3.6.4 Competitive Scenario 9.3.6.5 Regulatory Framework 9.3.6.6 Reimbursement Scenario 9.3.7 Denmark 9.3.7.1 Key Country Dynamics 9.3.7.2 Denmark Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.3.7.3 Target Disease Prevalence 9.3.7.4 Competitive Scenario 9.3.7.5 Regulatory Framework 9.3.7.6 Reimbursement Scenario 9.3.8 Sweden 9.3.8.1 Key Country Dynamics 9.3.8.2 Sweden Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.3.8.3 Target Disease Prevalence 9.3.8.4 Competitive Scenario 9.3.8.5 Regulatory Framework 9.3.8.6 Reimbursement Scenario 9.3.9 Norway 9.3.9.1 Key Country Dynamics 9.3.9.2 Italy Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.3.9.3 Target Disease Prevalence 9.3.9.4 Competitive Scenario 9.3.9.5 Regulatory Framework 9.3.9.6 Reimbursement Scenario 9.4 Asia Pacific 9.4.1 Asia Pacific Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.4.2 Japan 9.4.2.1 Key Country Dynamics 9.4.2.2 Japan Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.4.2.3 Target Disease Prevalence 9.4.2.4 Competitive Scenario 9.4.2.5 Regulatory Framework 9.4.2.6 Reimbursement Scenario 9.4.3 China 9.4.3.1 Key Country Dynamics 9.4.3.2 China Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.4.3.3 Target Disease Prevalence 9.4.3.4 Competitive Scenario 9.4.3.5 Regulatory Framework 9.4.3.6 Reimbursement Scenario 9.4.4 India 9.4.4.1 Key Country Dynamics 9.4.4.2 India Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.4.4.3 Target Disease Prevalence 9.4.4.4 Competitive Scenario 9.4.4.5 Regulatory Framework 9.4.4.6 Reimbursement Scenario 9.4.5 South Korea 9.4.5.1 Key Country Dynamics 9.4.5.2 South Korea Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.4.5.3 Target Disease Prevalence 9.4.5.4 Competitive Scenario 9.4.5.5 Regulatory Framework 9.4.5.6 Reimbursement Scenario 9.4.6 Australia 9.4.6.1 Key Country Dynamics 9.4.6.2 Australia Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.4.6.3 Target Disease Prevalence 9.4.6.4 Competitive Scenario 9.4.6.5 Regulatory Framework 9.4.6.6 Reimbursement Scenario 9.4.7 Thailand 9.4.7.1 Key Country Dynamics 9.4.7.2 Thailand Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.4.7.3 Target Disease Prevalence 9.4.7.4 Competitive Scenario 9.4.7.5 Regulatory Framework 9.4.7.6 Reimbursement Scenario 9.5 Latin America 9.5.1 Latin America Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.5.2 Brazil 9.5.2.1 Key Country Dynamics 9.5.2.2 Brazil Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.5.2.3 Target Disease Prevalence 9.5.2.4 Competitive Scenario 9.5.2.5 Regulatory Framework 9.5.2.6 Reimbursement Scenario 9.5.4 Argentina 9.5.4.1 Key Country Dynamics 9.5.4.2 Argentina Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.5.4.3 Target Disease Prevalence 9.5.4.4 Competitive Scenario 9.5.4.5 Regulatory Framework 9.5.4.6 Reimbursement Scenario 9.6 MEA 9.6.1 MEA Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.6.2 South Africa 9.6.2.1 Key Country Dynamics 9.6.2.2 South Africa Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.6.2.3 Target Disease Prevalence 9.6.2.4 Competitive Scenario 9.6.2.5 Regulatory Framework 9.6.2.6 Reimbursement Scenario 9.6.3 Saudi Arabia 9.6.3.1 Key Country Dynamics 9.6.3.2 Saudi Arabia Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.6.3.3 Target Disease Prevalence 9.6.3.4 Competitive Scenario 9.6.3.5 Regulatory Framework 9.6.3.6 Reimbursement Scenario 9.6.4 UAE 9.6.4.1 Key Country Dynamics 9.6.4.2 UAE Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.6.4.3 Target Disease Prevalence 9.6.4.4 Competitive Scenario 9.6.4.5 Regulatory Framework 9.6.4.6 Reimbursement Scenario 9.6.5 Kuwait 9.6.5.1 Key Country Dynamics 9.6.5.2 Kuwait Health Check-up Market Estimates And Forecasts, 2018 - 2030 (USD Million) 9.6.5.3 Target Disease Prevalence 9.6.5.4 Competitive Scenario 9.6.5.5 Regulatory Framework 9.6.5.6 Reimbursement Scenario Chapter 10 Competitive Landscape 10.1 Company Categorization 10.2 Strategy Mapping 10.2.1 New Product Launch 10.2.2 Partnerships 10.2.3 Acquisition 10.2.4 Collaboration 10.2.5 Funding 10.3 Key Company Market Share Analysis, 2022 10.4 Company Profiles 10.4.1 Quest Diagnostics Incorporated 10.4.1.1 Company Overview 10.4.1.2 Financial Performance 10.4.1.3 Product Benchmarking 10.4.1.4 Strategic Initiatives 10.4.2 Laboratory Corporation Of America Holdings 10.4.2.1 Company Overview 10.4.2.2 Financial Performance 10.4.2.3 Product Benchmarking 10.4.2.4 Strategic Initiatives 10.4.3 Synlab International Gmbh 10.4.3.1 Company Overview 10.4.3.2 Financial Performance 10.4.3.3 Product Benchmarking 10.4.3.4 Strategic Initiatives 10.4.4 Bioreference Health, Llc 10.4.4.1 Company Overview 10.4.4.2 Financial Performance 10.4.4.3 Product Benchmarking 10.4.4.4 Strategic Initiatives 10.4.5 Eurofins Scientific 10.4.5.1 Company Overview 10.4.5.2 Financial Performance 10.4.5.3 Product Benchmarking 10.4.5.4 Strategic Initiatives 10.4.6 Sonic Healthcare Limited 10.4.6.1 Company Overview 10.4.6.2 Financial Performance 10.4.6.3 Product Benchmarking 10.4.6.4 Strategic Initiatives 10.4.7 Arup Laboratories 10.4.7.1 Company Overview 10.4.7.2 Financial Performance 10.4.7.3 Product Benchmarking 10.4.7.4 Strategic Initiatives 10.4.8 Q2 Solutions 10.4.8.1 Company Overview 10.4.8.2 Financial Performance 10.4.8.3 Product Benchmarking 10.4.8.4 Strategic Initiatives 10.4.9 Unilabs 10.4.9.1 Company Overview 10.4.9.2 Financial Performance 10.4.9.3 Product Benchmarking 10.4.9.4 Strategic Initiatives 10.4.10 Lalpathlabs.com 10.4.10.1 Company Overview 10.4.10.2 Financial Performance 10.4.10.3 Product Benchmarking 10.4.10.4 Strategic Initiatives Chapter 11 Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Grand View Research社の臨床検査分野での最新刊レポート
本レポートと同じKEY WORD(cardiovascular)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/12/12 10:26 153.40 円 161.58 円 198.54 円 |